News Conference News ACC 2014 GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI Jason Kahn March 31, 2014
News Conference News ACC 2014 High-sensitivity Troponin Testing May Prevent Unnecessary Admissions for Chest Pain L.A. McKeown March 30, 2014
News Conference News ACC 2014 TAVR With the CoreValve Device Superior to Surgery at 1 Year Yael L. Maxwell March 29, 2014
News Conference News ACC 2013 SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI Caitlin E. Cox March 12, 2013
News Conference News ACC 2013 Coronary CTA Predictive, Resource-Saving When Used in Emergency Department Yael L. Maxwell March 11, 2013
News Conference News ACC 2013 Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months Jason Kahn March 11, 2013
News Conference News ACC 2013 Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients L.A. McKeown March 09, 2013
News Conference News ACC 2013 Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting Yael L. Maxwell March 08, 2013
News Conference News ACC 2012 Symplicity Works: Renal Denervation Reduces Resistant Hypertension Yael L. Maxwell March 27, 2012
News Conference News ACC 2012 Benefits of Transradial PCI May be Limited to High Volume Centers Jason Kahn March 27, 2012
News Conference News ACC 2012 ASCERT: Long-term Survival Advantage with CABG in Multivessel Disease Yael L. Maxwell March 27, 2012
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Conference News ACC 2012 Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS L.A. McKeown March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012